Protagonist Therapeutics, Inc (PTGX)

SEC filing

Protagonist Therapeutics, Inc

PTGX · CIK 1377121

4 · Mar 27, 2026 · SELICK HAROLD E sold 24K shares at $105.00/share ($2.5M); exercised options for 24K shares

SELICK HAROLD E sold 24K shares at $105.00/share ($2.5M); exercised options for 24K shares

OWNERSHIP DOCUMENT

xslF345X06/tm2610129-2_4seq1.xmlSEC.gov

Graphics and non-inline formats (not embedded below).